Allyn G. Mann Named Senior Manager of Luitpold's Animal Health Division

Allyn G. Mann has returned to Luitpold Pharmaceuticals, Inc., as senior manager of the Animal Health Division. Mann was most recently at Bayer HealthCare Animal Health Division, where he was the Equine Product Manager.

"Allyn's return to Luitpold was a happy reunion," said Mary Jane Helenek, President and CEO of Luitpold Pharmaceuticals, Inc, "and a great match. With his 20 years of experience in equine health, we are looking to Allyn to help us expand our presence in the industry and help us to continue building our equine franchise."
 
Mann was a sales representative for Luitpold's Animal Health Division, and then later was manager of marketing and technical services.  In that role, he assisted in the launch of Adequan i.m. (POLYSULFATED GLYCOSAMINOGLYCAN) and Equiphen Paste (PHENYLBUTAZONE). His equine animal health experience also includes positions held at Boehringer Ingelheim, Sterivet, and Triple Crown Pharmacal.

"I see terrific opportunities in front of us," said Mann. "The vision here at Luitpold is to develop a true equine franchise.  So, we will be looking at the kinds of things that can help us continue to grow. We hope to build something really special--and to become known to veterinarians as a meaningful resource."

Luitpold's divisions and subsidiaries include:

  • Luitpold Pharmaceuticals Animal Health, which makes Adequan i.m., Adequan  i.a. (POLYSULFATED GLYCOSAMINOGLYCAN), Equiphen Paste and Adequan Canine (POLYSULFATED GLYCOSAMINOGLYCAN). 
  • Osteohealth Co., which distributes products used in dental implantation and maxillofacial surgery, including Bio-Oss, Bio-Gide and Bio-Oss Collagen.
  • American Regent, Inc., which makes iron compounds including Dexferrum (IRON DEXTRAN INJECTION, USP) and Venofer (IRON SUCROSE INJECTION, USP).

More information about Luitpold Pharmaceuticals, Inc., is available at www.luitpold.com.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners